Press Releases

Feb 22, 2002 Hemispherx Defamation Trial Results in Claims of Both Parties Being Denied Jury Fails To Award Damages Against Asensio;

Jan 28, 2002 Hemispherx Continues To Enroll New Clinical Investigators And Expand Clinical Trial Sites In HIV Trials Company Also Prepares To Present At Upcoming Scientific Conferences

Dec 04, 2001 Hemispherx Comments on New Report From U.S. Agency for Healthcare Research and Quality -- AHRQ -- on Chronic Fatique Syndrome -- CFS --

Nov 14, 2001 HEMISPHERx ANNOUNCES THIRD QUARTER FINANCIAL RESULTS

Nov 01, 2001 Hemispherx Biopharma Will Announce New HIV Clinical Treatment Data On Immune Intervention during "Drug Holidays" at WHO Conference

Oct 17, 2001 Hemispherx Awarded U.S. Patent on Novel Fusion Inhibitor of HIV

Oct 04, 2001 HEMISPHERX REPORTS ON PROGRESS IN EUROPE -- Steady Organizational Growth Since February 2000 Prepares Company For European Trials And Product Introduction

Oct 02, 2001 Hemispherx Biopharma Announces Notice Of Warrant Expiration Date

Oct 02, 2001 Hemispherx Scientists Report New Method To Evaluate Chronic Fatigue Syndrome

Jul 24, 2001 HEMISPHERX BIOPHARMA SELECTED BY MSN MONEY CENTRAL'S STOCKSCOUTER AS ONE OF HIGHEST RATED SMALL-CAP BIOTECHS

68 69 70 71 72 73 74

<< < > >>